Impact of Promoting Community Initiated Kangaroo Mother Care (KMC) for Low Birth Weight Infants (KMC-LBW)

December 6, 2018 updated by: Society for Applied Studies

This study is being conducted to assess the impact of promoting community initiated Kangaroo Mother Care (ciKMC) for low birth weight babies on post enrolment neonatal mortality and mortality post enrolment upto 6 months of age. This large individually randomized controlled trial will enroll 10500 low birth weight babies. The secondary objectives are examining the impact of the intervention on exclusive breast feeding and growth at 1 and 3 months, infections and hospitalizations in the neonatal period and from 1 to 5 months of age, recognition of illnesses and early care seeking from appropriate sources, motor and mental development in a subsample.

Newborns weighing >=1500 to <=2250gm are being enrolled into the study within 3 days of birth. Eligible babies are randomized to intervention or control arms. Mothers in the intervention arm are supported for KMC and breastfeeding by study ANM (Auxiliary Nurse Midwife) and study ASHA (Accredited Social Health Activist) like workers . Routine home visits are conducted in both intervention and control arms by government workers according to the existing government program.

Survival will be ascertained in all enrolled infants through contacts at 1, 3 and 6 months.

The data safety and monitoring committee (DSMC) conducted two interim analyses, first in September 2017 when about half of the infants had been enrolled, and second in June 2018, when almost three quarters of the enrolled babies had been followed till 28 days of age. Following the second interim analysis, the DSMC concluded that a sufficient number of infants would be enrolled by the end to September 2018 to clearly answer the study question concerning the impact of ciKMC on both neonatal and early infant mortality. The DSMC recommended that data collection be completed by the end of October 2018.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

8402

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Haryana
      • Palwal, Haryana, India, 121102
        • CHRD, Society for Applied Studies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 3 days (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Low birth weight babies (≥1500 to ≤2250 g) screened within 3 days and their mothers.

  • Born at home
  • Singleton or twins or triplets
  • Infants born in hospital, discharged and KMC not initiated in the hospital

Exclusion Criteria:

  • Infant unable to feed
  • Infant has breathing problem
  • Infant is less active than normal
  • Gross congenital malformations
  • Mother does not intend to stay in the study area for the next 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Kangaroo Mother Care
Promotion of, and support for lactation management and skin to skin care as soon as possible after birth by study ANM supported by study ASHA in addition to routine visits by government health workers
Promotion of, and support for lactation management and skin to skin care as soon as possible after birth by study ANM supported by study ASHA in addition to routine visits by government health workers
No Intervention: Control
Routine visits by government health workers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Neonatal mortality from post enrolment to 28 days
Time Frame: From post enrolment to 28 days
From post enrolment to 28 days
Early infant mortality from post enrolment to 6 months of age
Time Frame: From post enrolment to 6 months
From post enrolment to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion exclusively breastfed at 1 and 3 months
Time Frame: 1 month, 3 months
1 month, 3 months
Weight gain
Time Frame: 1, 3 and 6 months
1, 3 and 6 months
Length gain
Time Frame: 1, 3 and 6 months
1, 3 and 6 months
Incidence of infection and hospitalization
Time Frame: 1 month and 1 to 5 months
1 month and 1 to 5 months
Early recognition of illness at 1 month
Time Frame: 1 month period
Recognition of illness will be ascertained from caregivers by using questionnaire
1 month period
Early appropriate care seeking practices at 1 month
Time Frame: 1 month period
Early appropriate care seeking ascertained from caregivers by using questionnaire
1 month period
Early recognition of illness at 3 months
Time Frame: Assessed at 3 months, data from 1 month upto 3 months
Recognition of illness ascertained from caregivers by using questionnaire
Assessed at 3 months, data from 1 month upto 3 months
Early appropriate care seeking practices at 3 months
Time Frame: Assessed at 3 months, data from 1 month upto 3 months
Early appropriate care-seeking ascertained from caregivers by using questionnaire
Assessed at 3 months, data from 1 month upto 3 months
Early recognition of illness at 6 months
Time Frame: Assessed at 6 months, data from 3 months upto 6 months
Recognition of illness ascertained from caregivers by using questionnaire
Assessed at 6 months, data from 3 months upto 6 months
Early appropriate care seeking practices at 6 months
Time Frame: Assessed at 6 months, data from 3 months upto 6 months
Early appropriate care-seeking practices ascertained by using questionnaire
Assessed at 6 months, data from 3 months upto 6 months
Assessment of cognitive function by Bayley scale in a subsample
Time Frame: Assessment of cognitive function by Bayley scale at 6 months
Assessment of cognitive function by Bayley scale at 6 months
Assessment of cognitive function by Bayley scale in a subsample
Time Frame: Assessment of cognitive function by Bayley scale at 12 months
Assessment of cognitive function by Bayley scale at 12 months
Head circumference
Time Frame: 1, 3 and 6 months
1, 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr. Sarmila Mazumder, MBBS, PhD, Society for Applied Studies

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

October 1, 2018

Study Completion (Actual)

October 1, 2018

Study Registration Dates

First Submitted

December 26, 2015

First Submitted That Met QC Criteria

January 9, 2016

First Posted (Estimate)

January 12, 2016

Study Record Updates

Last Update Posted (Actual)

December 7, 2018

Last Update Submitted That Met QC Criteria

December 6, 2018

Last Verified

December 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2015/1486/REK vest

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low-Birth-Weight

Clinical Trials on Kangaroo Mother Care

3
Subscribe